{"groups":[{"description":"Taken orally twice daily (continuous 28 day treatment cycles)","id":"FG000","title":"Rucaparib 600 mg Tablets"},{"description":"Taken orally twice daily (continuous 28 day treatment cycles)","id":"FG001","title":"Placebo Tablets"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"375"},{"groupId":"FG001","numSubjects":"189"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"375"},{"groupId":"FG001","numSubjects":"189"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}],"recruitmentDetails":"564 subjects were recruited from 87 sites across 11 countries and randomized (2:1) to treatment with rucaparib or placebo"}